NEW YORK (Reuters Health) – Results of a meta-analysis indicate that patients with chronic kidney disease (CKD) derive little net benefit from antiplatelet therapy in terms of cardiovascular…
NEW YORK (Reuters Health) – Golimumab, a new anti-TNF monoclonal antibody, administered subcutaneously every 4 weeks, shows sustained efficacy in reducing signs and symptoms of active psoriatic arthritis…
NEW YORK (Reuters Health) – Intraoperative hypothermia to less than 35 C more than doubles the risk of surgical site infections after trauma laparotomy, according to a report…
NEW YORK (Reuters Health) – The 20-year survival rate for people diagnosed with thin or T1 melanomas 1 mm thick or less, the most common type, is 96%,…
NEW YORK (Reuters Health) – Results of a randomized study provide no evidence of benefit from high-concentration oxygen therapy relative to titrated oxygen therapy in patients with initially…
NEW YORK (Reuters Health) – In a small randomized study of patients with infected necrotizing pancreatitis, minimally invasive endoscopic transgastric necrosectomy was associated with a lower risk of…
NEW YORK (Reuters Health) – When patients with advanced gastric cancer have not benefitted from one or two chemotherapy regimens for metastatic disease, salvage chemotherapy improves their overall…
NEW YORK (Reuters Health) – Results of a study conducted in Singapore indicate that vasopressin administered to patients in prolonged cardiac arrest does not improve survival to hospital…
NEW YORK (Reuters Health) – In high-risk hypertensive patients with or without prior coronary artery disease, adding the angiotensin receptor II blocker valsartan to conventional non-ARB treatment reduces…
NEW YORK (Reuters Health) – Two independent studies have shown that reduced-activity variants of the cytochrome P450 2D6 (CYP2D6) enzyme are not associated with poorer disease control in…
